Antisense antibacterial method and composition
CA 2392685 C · Owner: Avi Biopharma, Inc. · Inventors: Iversen, Patrick L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to compositions comprising oligomers antisense to bacterial 16S or 23S rRNA and capable of selectively modulating the biological activity thereof and methods for their , use. More particularly the invention relates to antisense, oligomers directed to 16S or 23S rRNA found in one or more particular bacteria, or generally conserved among bacteria in general and to pharmaceutical compositions and methods of treatment comprising the same.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 29, 2000 and granted February 22, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 29, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 29, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.